Blog

Rochester is at the forefront of developing new E. coli vaccine

Posted on October 23, 2019 in Vaccines

Rochester is at the forefront of developing new E. coli vaccine

Antibiotic-Resistant Strains Posing Life-Threatening E. Coli Infections. This vaccine may cover several of those strains.

Ebola Vaccine Now Used in Africa

Posted on August 7, 2019 in Vaccines

Rochester Clinical Research conducted an Ebola Vaccine Research study that is currently being used in Africa. It has been 99% effective for those who have gotten the vaccine.

Can a Single Pill Keep you Healthy to 100? A Clinical Trial at RCR Will Soon Find Out.

Posted on July 1, 2019 in General

Rochester Clinical Research is proud to be a part of the cutting-edge research for the investigational drug RTB101, developed by resTORbio. The drug is aimed to arrest aging at a cellular level and has been studied for the past 15 years. This could lead not to a longer life, but a better life. RCR will be enrolling for a study with the RTB101 drug this fall 2019. For those interested in participating, we invite you to call us at 585-288-0890 or click the link to learn more.

Smallpox Vaccine Needed for Risk of Bioterrorism

Posted on April 29, 2019 in General Vaccines

Routine vaccinations for smallpox ended 40 years ago after the World Health Organization officially declared global eradication of smallpox. This means the majority of the population is not protected. The threat of bioterrorism and natural re-emergence has prompted the US and countries around the world to prepare an updated vaccine which is more effective and easier to store. RCR is currently on the forefront of developing this vaccine.

RCR’s State of the Union Address

Posted on April 15, 2019 in General

Each year, Rochester Clinical Research hosts a State of the Union address in March for all of the employees. The meeting recaps the year and looks to future plans that align with our mission – to excel in our field by providing quality care for study volunteers, quality data for sponsors and a quality team-oriented […]

RCR Highlighted on WHEC News 10: Rochester Innovation

Posted on March 18, 2019 in General

Pat Larrabee, Founder and CEO of RCR was interviewed by News 10 on March 8, 2019. She spoke about the company and the many volunteers who have become Research Heroes in the Greater Rochester area. Click here to watch the clip.

Lyme Disease Vaccine Needed with Widespread of Disease

Posted on January 29, 2019 in General

Rochester is at the forefront of researching a new Lyme disease vaccine. Rochester, N.Y. – Each year, approximately 30,000 cases of Lyme disease are reported to the CDC and recent estimates using other methods suggest that approximately 300,000 people may get Lyme disease each year in the United States. While antibiotics can help treat […]